These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9003578)

  • 1. Structural modeling: simultaneous pharmacokinetic-pharmacodynamic modeling.
    Gambús PL
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl C():47-8. PubMed ID: 9003578
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternatives to structural modeling.
    Veng-Pedersen P
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl C():49-50. PubMed ID: 9003579
    [No Abstract]   [Full Text] [Related]  

  • 3. Grounds for the integration of pharmacokinetic-pharmacodynamic data.
    Barbanoj MJ; Salazar G; Morte A; Antonijoan RM; Gich I; Jané F
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl C():43-5. PubMed ID: 9003577
    [No Abstract]   [Full Text] [Related]  

  • 4. Qualitative pharmacokinetic modeling of drugs.
    Boyce R; Collins C; Horn J; Kalet IJ
    AMIA Annu Symp Proc; 2005; 2005():71-5. PubMed ID: 16779004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic/pharmacodynamic modeling in drug development.
    Sheiner LB; Steimer JL
    Annu Rev Pharmacol Toxicol; 2000; 40():67-95. PubMed ID: 10836128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
    Chen ML
    Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic/pharmacodynamic modeling in drug research and development.
    Derendorf H; Lesko LJ; Chaikin P; Colburn WA; Lee P; Miller R; Powell R; Rhodes G; Stanski D; Venitz J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1399-418. PubMed ID: 11185661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.
    Danhof M; de Lange EC; Della Pasqua OE; Ploeger BA; Voskuyl RA
    Trends Pharmacol Sci; 2008 Apr; 29(4):186-91. PubMed ID: 18353445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development.
    Yu XQ; Wilson AG
    Future Med Chem; 2010 Jun; 2(6):923-8. PubMed ID: 21426110
    [No Abstract]   [Full Text] [Related]  

  • 10. A program for the optimum design of pharmacokinetic, pharmacodynamic, drug metabolism and drug-drug interaction models.
    Graham G; Gueorguieva I; Dickens K
    Comput Methods Programs Biomed; 2005 Jun; 78(3):237-49. PubMed ID: 15899308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic/pharmacodynamic modeling: what it is!
    Colburn WA
    J Pharmacokinet Biopharm; 1987 Oct; 15(5):545-55. PubMed ID: 3694497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A regulatory perspective on pharmacokinetic/pharmacodynamic modelling.
    Machado SG; Miller R; Hu C
    Stat Methods Med Res; 1999 Sep; 8(3):217-45. PubMed ID: 10636336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pk-fit: a pharmacokinetic/pharmacodynamic and statistical data analysis software.
    Farenc C; Fabreguette JR; Bressolle F
    Comput Biomed Res; 2000 Oct; 33(5):315-29. PubMed ID: 11017724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The integration of pharmacokinetics and pharmacodynamics: understanding dose-response.
    Abdel-Rahman SM; Kauffman RE
    Annu Rev Pharmacol Toxicol; 2004; 44():111-36. PubMed ID: 14744241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interactions and incompatibilities in prescription drugs. Incidents in dental surgery].
    Tillement JP; Hannaire C; Grandidier M; Albengres E
    Ann Pharm Fr; 2000 Jul; 58(4):247-53. PubMed ID: 10915972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical cross-over trials in phase I.
    Senn S; Ezzet F
    Stat Methods Med Res; 1999 Sep; 8(3):263-78. PubMed ID: 10636338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Principles and perspectives of clinical pharmacology].
    Kaufmann W
    Klin Wochenschr; 1991; 69 Suppl 26():8-12. PubMed ID: 1813734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative structure-pharmacokinetic/pharmacodynamic relationships.
    Mager DE
    Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1326-56. PubMed ID: 17092600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-based pharmacokinetic-pharmacodynamic modeling-a new classification of biomarkers.
    Danhof M; Alvan G; Dahl SG; Kuhlmann J; Paintaud G
    Pharm Res; 2005 Sep; 22(9):1432-7. PubMed ID: 16132354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic modeling in vivo.
    Holford NH; Sheiner LB
    Crit Rev Bioeng; 1981; 5(4):273-322. PubMed ID: 7023829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.